EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank93
3Y CAGR+76.7%
5Y CAGR+189.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+76.7%/yr
vs +114.3%/yr prior
5Y CAGR
+189.3%/yr
Recent deceleration
Acceleration
-37.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
202.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$11.75M-22.1%
2024$15.09M+117.1%
2023$6.95M+226.1%
2022$2.13M+629.8%
2021$292000.00+403.4%
2020$58000.00-94.5%
2019$1.05M+943.6%
2018$101000.00+11.0%
2017$91000.000.0%
2016$91000.00-